| name | bio-clinical-databases-hla-typing |
| description | Call HLA alleles from NGS data using OptiType, HLA-HD, or arcasHLA for immunogenomics applications. Use when determining HLA genotype for transplant matching, neoantigen prediction, or pharmacogenomic screening. |
| tool_type | cli |
| primary_tool | OptiType |
Version Compatibility
Reference examples tested with: OptiType 1.3+, STAR 2.7.11+, pandas 2.2+, samtools 1.19+
Before using code patterns, verify installed versions match. If versions differ:
- Python:
pip show <package> then help(module.function) to check signatures
- CLI:
<tool> --version then <tool> --help to confirm flags
If code throws ImportError, AttributeError, or TypeError, introspect the installed
package and adapt the example to match the actual API rather than retrying.
HLA Typing
"Determine HLA genotype from my sequencing data" → Call HLA alleles from WGS/WES/RNA-seq reads for transplant matching, neoantigen prediction, or pharmacogenomic screening.
- CLI:
OptiType for HLA class I typing from DNA/RNA reads
- CLI:
arcasHLA extract → arcasHLA genotype for RNA-seq based typing
OptiType (HLA Class I)
Goal: Call HLA Class I alleles (HLA-A, B, C) at 4-field resolution from WGS, WES, or RNA-seq data.
Approach: Extract HLA region reads from BAM, then run OptiType's integer linear programming algorithm to determine optimal allele assignment.
From DNA-seq
samtools view -h input.bam chr6:28000000-34000000 | \
samtools fastq -1 hla_R1.fq -2 hla_R2.fq -
OptiTypePipeline.py \
-i hla_R1.fq hla_R2.fq \
-d \
-o optitype_output \
-c config.ini
From RNA-seq
OptiTypePipeline.py \
-i rna_R1.fq rna_R2.fq \
-r \
-o optitype_rna_output \
-c config.ini
OptiType Config
[mapping]
razers3=/path/to/razers3
threads=4
[ilp]
solver=glpk
threads=4
[behavior]
deletebam=true
unpaired_weight=0
use_discordant=false
HLA-HD (Full Resolution)
Goal: Perform high-resolution HLA typing for both Class I and Class II loci from WGS/WES data.
Approach: Extract HLA-region reads, then run HLA-HD which uses Bowtie2 mapping against the IPD-IMGT/HLA database.
samtools view -b input.bam chr6:28000000-34000000 > hla_region.bam
samtools sort -n hla_region.bam -o hla_sorted.bam
samtools fastq -1 hla_R1.fq -2 hla_R2.fq hla_sorted.bam
hlahd.sh \
-t 8 \
-m 100 \
-f freq_data \
hla_R1.fq \
hla_R2.fq \
gene_split_filt \
dictionary \
sample_name \
output_dir
arcasHLA (RNA-seq)
Goal: Genotype HLA alleles directly from RNA-seq BAM files aligned with STAR.
Approach: Extract HLA-mapped reads with arcasHLA extract, then genotype using an EM algorithm against the IMGT/HLA database.
arcasHLA extract sample.bam -o output_dir
arcasHLA genotype output_dir/sample.extracted.fq.gz -o output_dir
arcasHLA Merge
arcasHLA merge output_dir/*.genotype.json -o merged_hla.tsv
HLA Nomenclature
HLA-A*02:01:01:01
| | | |
| | | +-- Non-coding variation (optional)
| | +----- Synonymous variation (optional)
| +-------- Protein sequence (usually reported)
+----------- Allele group
Resolution levels:
- 2-field: A*02:01 (protein sequence - clinical standard)
- 4-field: A*02:01:01 (includes synonymous changes)
- Full: A*02:01:01:01 (includes non-coding)
HLA and Pharmacogenomics
Goal: Screen patient HLA alleles for known drug hypersensitivity associations.
Approach: Cross-reference called HLA alleles against a curated table of HLA-drug adverse reaction associations.
HLA_DRUG_ASSOCIATIONS = {
'B*57:01': {
'drug': 'Abacavir',
'reaction': 'Hypersensitivity syndrome',
'screening': 'Required before prescribing'
},
'B*15:02': {
'drug': 'Carbamazepine',
'reaction': 'SJS/TEN',
'populations': 'High risk in Han Chinese, Southeast Asian'
},
'B*58:01': {
'drug': 'Allopurinol',
'reaction': 'SJS/TEN',
'populations': 'High risk in Han Chinese, Korean, Thai'
},
'A*31:01': {
'drug': 'Carbamazepine',
'reaction': 'DRESS',
'populations': 'European, Japanese'
}
}
def check_hla_drug_risk(hla_alleles, drug):
'''Check if patient HLA poses drug reaction risk'''
risks = []
for allele in hla_alleles:
if allele in HLA_DRUG_ASSOCIATIONS:
assoc = HLA_DRUG_ASSOCIATIONS[allele]
if assoc['drug'].lower() == drug.lower():
risks.append({
'allele': allele,
'drug': drug,
'reaction': assoc['reaction']
})
risks
Parse OptiType Results
Goal: Parse OptiType TSV output into structured HLA calls and format for clinical reporting.
Approach: Read the tab-separated result file and extract allele pairs for each HLA locus.
import pandas as pd
def parse_optitype(result_file):
'''Parse OptiType TSV output'''
df = pd.read_csv(result_file, sep='\t')
hla_calls = {
'HLA-A': [df['A1'].iloc[0], df['A2'].iloc[0]],
'HLA-B': [df['B1'].iloc[0], df['B2'].iloc[0]],
'HLA-C': [df['C1'].iloc[0], df['C2'].iloc[0]]
}
return hla_calls
def format_hla_report(hla_calls):
'''Format HLA calls for clinical report'''
report = []
for gene, alleles in hla_calls.items():
allele_str = '/'.join(sorted(set(alleles)))
report.append(f'{gene}: {allele_str}')
return '\n'.join(report)
Class I vs Class II
| Class | Genes | Function | Typing Priority |
|---|
| Class I | HLA-A, B, C | Present intracellular peptides | Neoantigen, PGx |
| Class II | HLA-DR, DQ, DP | Present extracellular peptides | Transplant, autoimmune |
Tool Comparison
| Tool | Input | Classes | Resolution | Speed |
|---|
| OptiType | WGS/WES/RNA | I only | 4-field | Fast |
| HLA-HD | WGS/WES | I and II | 4-field | Moderate |
| arcasHLA | RNA-seq | I and II | 4-field | Fast |
| HLA-LA | WGS | I and II | 4-field | Slow |
Related Skills
- clinical-databases/pharmacogenomics - HLA-drug interactions
- variant-calling/clinical-interpretation - Clinical reporting
- single-cell/cell-type-annotation - HLA expression